Advances in HIV-1 Envelope-Based Vaccine Development
As the sole viral protein expressed on the surface of viral particles and infected cells, the HIV-1 envelope glycoprotein is the most important target for vaccine development. Structurally defined sites of vulnerability recognized by broadly neutralizing antibodies (bNAbs) serve as major targets for vaccine design, inc...